ChemicalBook >> CAS DataBase List >>Enoxacin Impurity 8

Enoxacin Impurity 8

CAS No.
115274-26-5
Chemical Name:
Enoxacin Impurity 8
Synonyms
Enoxacin Impurity;Enoxacin Impurity 8;Betulinic Acid Impurity 5 (Betulinicaldehyde);1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-1-methyl-4-oxo-7-(1-piperazinyl)-
CBNumber:
CB54659380
Molecular Formula:
C14H15FN4O3
Molecular Weight:
306.29
MDL Number:
MOL File:
115274-26-5.mol

Enoxacin Impurity 8 Properties

Melting point 280-283 °C
Boiling point 566.4±50.0 °C(Predicted)
Density 1.437±0.06 g/cm3(Predicted)
pka 6.05±0.70(Predicted)

Enoxacin Impurity 8 Preparation Products And Raw materials

Raw materials

Preparation Products

Enoxacin Impurity 8 Suppliers

Global( 8)Suppliers
Supplier Tel Email Country ProdList Advantage
XinYao(Shenzhen) Biological Technology Co., Ltd. 0755-89880280 3004662104@qq.com China 1829 58
Jinan blalong chemical co. LTD 2710913286@.com 1513643261@qq.com China 14246 58
Meng Cheng Technology (Shanghai) Co., LTD 400-820-6829 sales@mitachieve.com China 8860 58
Shanghai Botuo Biotechnology Co., LTD 16621358918 botuopharma888@163.com China 9208 58
Shanghai Zerui Biotechnology Co., Ltd. 021-54580889 18321124657 731997554@qq.com China 10608 58
guoyungurui 18162595016; 18162595016 3287908757@qq.com China 10335 58
Henan Vcommend Consultrading Co., Ltd. 13393721940; 13393721940 sales@vcommend.com China 9985 58
Enoxacin Impurity 8 Enoxacin Impurity 1,8-Naphthyridine-3-carboxylic acid, 6-fluoro-1,4-dihydro-1-methyl-4-oxo-7-(1-piperazinyl)- Betulinic Acid Impurity 5 (Betulinicaldehyde) 115274-26-5
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept